The global Throat Cancer Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer form in the tissues of the throat (oropharynx).
This report aims to provide a comprehensive presentation of the global market for Throat Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Throat Cancer Therapeutics. This report contains market size and forecasts of Throat Cancer Therapeutics in global, including the following market information:
- Global Throat Cancer Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
There is an increase in the prevalence of throat cancer across the world despite advances in the research of therapeutics and the healthcare infrastructure. Throat cancer is one of the most prevalent cancer types in Europe, Asia, and North America. Additionally, the mortality rate of this indication has increased over the past few years in the US. This has resulted in a substantial unmet market that is attracting pharmaceutical vendors to introduce novel therapies to cater to the demand. Moreover, the increasing awareness programs by the vendors is expected to aid in the early diagnosis of throat cancer indications. These factors will fuel throat cancer therapeutics market growth during the forecast period.
We surveyed the Throat Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Throat Cancer Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Throat Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Surgery
- Radiotherapy
- Chemotherapy
Global Throat Cancer Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Throat Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Oropharyngeal Cancer
- Laryngeal Cancer
Global Throat Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Throat Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Throat Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Throat Cancer Therapeutics revenues share in global market, 2022 (%)
Key players include:
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Throat Cancer Therapeutics, market overview.
Chapter 2: Global Throat Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Throat Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Throat Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Throat Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Throat Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Throat Cancer Therapeutics Overall Market Size
2.1 Global Throat Cancer Therapeutics Market Size: 2022 VS 2030
2.2 Global Throat Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Throat Cancer Therapeutics Players in Global Market
3.2 Top Global Throat Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Throat Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Throat Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Throat Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Throat Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Throat Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Throat Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Throat Cancer Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Surgery
4.1.3 Radiotherapy
4.1.4 Chemotherapy
4.2 By Type - Global Throat Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Throat Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Throat Cancer Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Throat Cancer Therapeutics Market Size, 2022 & 2030
5.1.2 Oropharyngeal Cancer
5.1.3 Laryngeal Cancer
5.2 By Application - Global Throat Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Throat Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Throat Cancer Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Throat Cancer Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Throat Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Throat Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Throat Cancer Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Throat Cancer Therapeutics Revenue, 2018-2030
6.3.2 US Throat Cancer Therapeutics Market Size, 2018-2030
6.3.3 Canada Throat Cancer Therapeutics Market Size, 2018-2030
6.3.4 Mexico Throat Cancer Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Throat Cancer Therapeutics Revenue, 2018-2030
6.4.2 Germany Throat Cancer Therapeutics Market Size, 2018-2030
6.4.3 France Throat Cancer Therapeutics Market Size, 2018-2030
6.4.4 U.K. Throat Cancer Therapeutics Market Size, 2018-2030
6.4.5 Italy Throat Cancer Therapeutics Market Size, 2018-2030
6.4.6 Russia Throat Cancer Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Throat Cancer Therapeutics Market Size, 2018-2030
6.4.8 Benelux Throat Cancer Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Throat Cancer Therapeutics Revenue, 2018-2030
6.5.2 China Throat Cancer Therapeutics Market Size, 2018-2030
6.5.3 Japan Throat Cancer Therapeutics Market Size, 2018-2030
6.5.4 South Korea Throat Cancer Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Throat Cancer Therapeutics Market Size, 2018-2030
6.5.6 India Throat Cancer Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Throat Cancer Therapeutics Revenue, 2018-2030
6.6.2 Brazil Throat Cancer Therapeutics Market Size, 2018-2030
6.6.3 Argentina Throat Cancer Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Throat Cancer Therapeutics Revenue, 2018-2030
6.7.2 Turkey Throat Cancer Therapeutics Market Size, 2018-2030
6.7.3 Israel Throat Cancer Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Throat Cancer Therapeutics Market Size, 2018-2030
6.7.5 UAE Throat Cancer Therapeutics Market Size, 2018-2030
7 Throat Cancer Therapeutics Companies Profiles
7.1 Bristol-Myers Squibb Co.
7.1.1 Bristol-Myers Squibb Co. Company Summary
7.1.2 Bristol-Myers Squibb Co. Business Overview
7.1.3 Bristol-Myers Squibb Co. Throat Cancer Therapeutics Major Product Offerings
7.1.4 Bristol-Myers Squibb Co. Throat Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Co. Key News & Latest Developments
7.2 Eli Lilly and Co.
7.2.1 Eli Lilly and Co. Company Summary
7.2.2 Eli Lilly and Co. Business Overview
7.2.3 Eli Lilly and Co. Throat Cancer Therapeutics Major Product Offerings
7.2.4 Eli Lilly and Co. Throat Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly and Co. Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Company Summary
7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
7.3.3 F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Summary
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Throat Cancer Therapeutics Major Product Offerings
7.4.4 Merck & Co., Inc. Throat Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Merck & Co., Inc. Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Throat Cancer Therapeutics Major Product Offerings
7.5.4 Sanofi Throat Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Throat Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Throat Cancer Therapeutics Market Drivers in Global Market
Table 3. Throat Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Throat Cancer Therapeutics in Global Market
Table 5. Top Throat Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Throat Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Throat Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Throat Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Throat Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Throat Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Throat Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Throat Cancer Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Throat Cancer Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Throat Cancer Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Throat Cancer Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Throat Cancer Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Throat Cancer Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Bristol-Myers Squibb Co. Company Summary
Table 31. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Product Offerings
Table 32. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Co. Key News & Latest Developments
Table 34. Eli Lilly and Co. Company Summary
Table 35. Eli Lilly and Co. Throat Cancer Therapeutics Product Offerings
Table 36. Eli Lilly and Co. Throat Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly and Co. Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd. Company Summary
Table 39. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Product Offerings
Table 40. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 42. Merck & Co., Inc. Company Summary
Table 43. Merck & Co., Inc. Throat Cancer Therapeutics Product Offerings
Table 44. Merck & Co., Inc. Throat Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co., Inc. Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Throat Cancer Therapeutics Product Offerings
Table 48. Sanofi Throat Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Throat Cancer Therapeutics Segment by Type in 2022
Figure 2. Throat Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Throat Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Throat Cancer Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Throat Cancer Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Throat Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Throat Cancer Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Throat Cancer Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly and Co. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co., Inc. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
